| For: |
Hookman P, Barkin JS. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i13/1554.htm |
| Number | Citing Articles |
| 1 |
Jiaying Huo, Ziyan Wu, Weizheng Sun, Zhenhua Wang, Jihong Wu, Mingquan Huang, Bowen Wang, Baoguo Sun. Protective Effects of Natural Polysaccharides on Intestinal Barrier Injury: A Review. Journal of Agricultural and Food Chemistry 2022; 70(3) doi: 10.1021/acs.jafc.1c05966
|
| 2 |
Sharon X. H. Hu, Adel Ekladious. Common presentation of an uncommon disease. Internal Medicine Journal 2021; 51(12) doi: 10.1111/imj.15619
|
| 3 |
Akihiro FUJIMOTO, Hirokazu SUWA, Jun WATANABE, Masatoshi MOGAKI, Hidenobu MASUI, Kaoru NAGAHORI. A Case of Small Intestinal Fulminant Clostridium <I>Difficile</I> Enteritis in which the Patient's Life was Saved by Small Bowel Resection. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2019; 80(1) doi: 10.3919/jjsa.80.84
|
| 4 |
Hsiao-Lun Wei, Sung-Hsi Wei, Chien-Wen Huang, Chih-Hung Shih, Yi-Wen Huang, Min-Chi Lu, Jin-Chyr Hsu, Yi-Sheng Liou, Chien-Shun Chiou. Molecular typing and epidemiology of Clostridium difficile in respiratory care wards of central Taiwan. Journal of Microbiology, Immunology and Infection 2015; 48(1) doi: 10.1016/j.jmii.2013.03.014
|
| 5 |
Ralph B. D'Agostino, Sylva H. Collins, Karol M. Pencina, Yin Kean, Sherwood Gorbach. Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors. Clinical Infectious Diseases 2014; 58(10) doi: 10.1093/cid/ciu107
|
| 6 |
Ethan Gough, Henna Shaikh, Amee R. Manges. Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 2011; 53(10) doi: 10.1093/cid/cir632
|
| 7 |
Thais Simões Camargo, Moacyr Silva Junior, Luis Fernando Aranha Camargo, Veronica Pivetta Biotto, André Mario Doi, Paula Celia Mariko Koga, Carolina Nunes França, Marines Dalla Valle Martino. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods. Archives of Microbiology 2021; 203(4) doi: 10.1007/s00203-020-02148-8
|
| 8 |
Chaitanya Pant, Thomas J. Sferra, Abhishek Deshpande, Anil Minocha. Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner. European Journal of Internal Medicine 2011; 22(6) doi: 10.1016/j.ejim.2011.04.009
|
| 9 |
Yvonne Kleypas, Dennis McCubbin, Elizabeth S. Curnow. The Role of Environmental Cleaning in Health Care-Associated Infections. Critical Care Nursing Quarterly 2011; 34(1) doi: 10.1097/CNQ.0b013e31820480d3
|
| 10 |
A. Barney Hawthorne. Toxic dilatation of the colon. Medicine 2019; 47(4) doi: 10.1016/j.mpmed.2019.01.006
|
| 11 |
Massimo Sartelli, Mark A. Malangoni, Fikri M. Abu-Zidan, Ewen A. Griffiths, Stefano Di Bella, Lynne V. McFarland, Ian Eltringham, Vishal G. Shelat, George C. Velmahos, Ciarán P. Kelly, Sahil Khanna, Zaid M. Abdelsattar, Layan Alrahmani, Luca Ansaloni, Goran Augustin, Miklosh Bala, Frédéric Barbut, Offir Ben-Ishay, Aneel Bhangu, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Laura A. Canterbury, Fausto Catena, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria Elena Cocuz, Raul Coimbra, Charles H. Cook, Yunfeng Cui, Jacek Czepiel, Koray Das, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina Magdalena Dumitru, Catherine Eckert, Christian Eckmann, Edward H. Eiland, Mushira Abdulaziz Enani, Mario Faro, Paula Ferrada, Joseph Derek Forrester, Gustavo P. Fraga, Jean Louis Frossard, Rita Galeiras, Wagih Ghnnam, Carlos Augusto Gomes, Venkata Gorrepati, Mohamed Hassan Ahmed, Torsten Herzog, Felicia Humphrey, Jae Il Kim, Arda Isik, Rao Ivatury, Yeong Yeh Lee, Paul Juang, Luis Furuya-Kanamori, Aleksandar Karamarkovic, Peter K Kim, Yoram Kluger, Wen Chien Ko, Francis D. LaBarbera, Jae Gil Lee, Ari Leppaniemi, Varut Lohsiriwat, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick Alan Moore, Carl Erik Nord, Carlos A. Ordoñez, Gerson Alves Pereira Júnior, Nicola Petrosillo, Francisco Portela, Basant K. Puri, Arnab Ray, Mansoor Raza, Miran Rems, Boris E. Sakakushev, Gabriele Sganga, Patrizia Spigaglia, David B. Stewart, Pierre Tattevin, Jean Francois Timsit, Kathleen B. To, Cristian Tranà, Waldemar Uhl, Libor Urbánek, Harry van Goor, Angela Vassallo, Jean Ralph Zahar, Emanuele Caproli, Pierluigi Viale. WSES guidelines for management of Clostridium difficile infection in surgical patients. World Journal of Emergency Surgery 2015; 10(1) doi: 10.1186/s13017-015-0033-6
|
| 12 |
M. Kazanowski, S. Smolarek, F. Kinnarney, Z. Grzebieniak. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities—a systematic review. Techniques in Coloproctology 2014; 18(3) doi: 10.1007/s10151-013-1081-0
|
| 13 |
Hye Sun Park, Dong Soo Han. Management of Antibiotics-Associated Diarrhea. The Korean Journal of Gastroenterology 2009; 54(1) doi: 10.4166/kjg.2009.54.1.5
|
| 14 |
Kirsty Skinner, Stephen Birchall, David Corbett, Pia Thommes, Hans H. Locher. Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile. Journal of Medical Microbiology 2018; 67(9) doi: 10.1099/jmm.0.000808
|
| 15 |
Veroljub Marković, Marina Kostić, Ivana Iličković, Slobodan M. Janković. Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition. Value in Health Regional Issues 2014; 4 doi: 10.1016/j.vhri.2014.08.001
|
| 16 |
Sergey S. Seregin, Yasser A. Aldhamen, David P.W. Rastall, Sarah Godbehere, Andrea Amalfitano. Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine 2012; 30(8) doi: 10.1016/j.vaccine.2011.12.064
|
| 17 |
Bruce E Hirsch, Nimit Saraiya, Kaitlin Poeth, Rebecca M Schwartz, Marcia E Epstein, Gerard Honig. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0930-z
|
| 18 |
Christopher B Tan, Dhyan Rajan, Mitanshu Shah, Shadab Ahmed, Lester Freedman, Kaleem Rizvon, Paul Mustacchia. Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine. BMJ Case Reports 2012; 2012 doi: 10.1136/bcr-2012-006460
|
| 19 |
|
| 20 |
Eunhak Seong, Sookyoung Lim, Myeongjong Lee, Hojun Kim. A Study of Antimicrobial Activity of Herbal Extracts on Clostridium difficile. Journal of Korean Medicine Rehabilitation 2021; 31(1) doi: 10.18325/jkmr.2021.31.1.47
|
| 21 |
Mayuresh M. Abhyankar, Jennie Z. Ma, Kenneth W. Scully, Andrew J. Nafziger, Alyse L. Frisbee, Mahmoud M. Saleh, Gregory R. Madden, Ann R. Hays, Mendy Poulter, William A. Petri, Martin J. Blaser. Immune Profiling To Predict Outcome of Clostridioides difficile Infection. mBio 2020; 11(3) doi: 10.1128/mBio.00905-20
|
| 22 |
J. B. Rosen, M. G. Schecter, J. S. Heinle, E. D. McKenzie, D. L. Morales, M. K. Dishop, L. Danziger-Isakov, G. B. Mallory, O. Elidemir. Clostridium difficile colitis in children following lung transplantation. Pediatric Transplantation 2010; 14(5) doi: 10.1111/j.1399-3046.2010.01314.x
|
| 23 |
Krista Vitikainen, Merit Kase, Leo Meriranta, Pauliina Molander, Clas-Göran af Björkesten, Veli-Jukka Anttila, Perttu Arkkila. Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251318292
|
| 24 |
Jiawen Shou, Ting Fu. The gut microbiome–bile acid-FXR interplay: a pivotal axis in metabolic and gastrointestinal diseases. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2665890
|
| 25 |
Leila Zarepoor, Jenifer T. Lu, Claire Zhang, Wenqing Wu, Dion Lepp, Lindsay Robinson, Janitha Wanasundara, Steve Cui, Sébastien Villeneuve, Bourlaye Fofana, Rong Tsao, Geoffrey A. Wood, Krista A. Power. Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(12) doi: 10.1152/ajpgi.00253.2013
|
| 26 |
S. Buyse, V. Peigne, M. Darmon, V. Lemiale, N. Munoz-Bongrand, B. Schlemmer, E. Azoulay. Réanimation hépatosplanchnique. 2010; doi: 10.1016/B978-2-8101-0186-3.50021-7
|
| 27 |
Daniel Paredes-Sabja, Mahfuzur R. Sarker. Adherence of Clostridium difficile spores to Caco-2 cells in culture.
Journal of Medical Microbiology
2012; 61(9) doi: 10.1099/jmm.0.043687-0
|
| 28 |
Hidekazu TAKATSUKA, Taro SASAYAMA, Nao TAKAKI. . Japanese Journal of Environmental Infections 2010; 25(5) doi: 10.4058/jsei.25.272
|
| 29 |
Yuichi Muraki, Masaki Tanabe, Akiko Nakamura, Yoshiko Matsushima, Masayuki Senoo, Midori Fukuda, Masahiro Okuda. Evaluation of Hospital Information System-linked Notification System Concerning Usage of Broad-Spectrum Antimicrobials. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2010; 36(5) doi: 10.5649/jjphcs.36.316
|
| 30 |
Gustavo Hideki Kawanami, Carlos Magno Castelo Branco Fortaleza. Factors predictive of inappropriateness in requests for parenteral antimicrobials for therapeutic purposes: A study in a small teaching hospital in Brazil. Scandinavian Journal of Infectious Diseases 2011; 43(6-7) doi: 10.3109/00365548.2011.565795
|
| 31 |
Elisabetta Antonelli, Monia Baldoni, Paolo Giovenali, Vincenzo Villanacci, Murad Essatari, Gabrio Bassotti. Intestinal superinfections in patients with inflammatory bowel diseases. Journal of Crohn's and Colitis 2012; 6(2) doi: 10.1016/j.crohns.2011.07.012
|
| 32 |
Seth Squires, Allan Boal, Fiona McCluskey. A ward nurse's guide to inflammatory bowel disease (part 1): screening, observation and investigation. Gastrointestinal Nursing 2018; 16(6) doi: 10.12968/gasn.2018.16.6.32
|
| 33 |
M. Schmidt-Hieber, J. Bierwirth, D. Buchheidt, O. A. Cornely, M. Hentrich, G. Maschmeyer, E. Schalk, J. J. Vehreschild, Maria J. G. T. Vehreschild. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Hematology 2018; 97(1) doi: 10.1007/s00277-017-3183-7
|
| 34 |
Mónica Millán Scheiding, Jose Sáez Hernandez, Jaime López Borao, Jordi Guardiola Capón, Sebastiano Biondo. Colitis fulminante por Clostridium difficile. Cirugía Española 2011; 89(8) doi: 10.1016/j.ciresp.2010.05.022
|
| 35 |
Mary Ann Jessee. Stool Studies: Tried, True, and New. Critical Care Nursing Clinics of North America 2010; 22(1) doi: 10.1016/j.ccell.2009.10.006
|
| 36 |
Manuel Ferrer Márquez, Álvaro Hernández Martínez, Ángel Reina Duarte, Rafael Rosado Cobián. Estado actual del tratamiento de la colitis fulminante. Cirugía Española 2015; 93(5) doi: 10.1016/j.ciresp.2014.09.016
|
| 37 |
Matthias A. Oberli, Marie-Lyn Hecht, Pascal Bindschädler, Alexander Adibekian, Thomas Adam, Peter H. Seeberger. A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic. Chemistry & Biology 2011; 18(5) doi: 10.1016/j.chembiol.2011.03.009
|
| 38 |
Pamela R. Walters, Brian S. Zuckerbraun. Clostridium difficile Infection: Clinical Challenges and Management Strategies. Critical Care Nurse 2014; 34(4) doi: 10.4037/ccn2014822
|
| 39 |
Hugo J.R. Bonatti, Jessica L. Hata, Michael A. Vella, Chanjuan Shi, William H. Nealon, Addison K. May. Failure to Recognize the Diagnosis of Cytomegalovirus Colitis in an Immunocompetent Male: Need for Heightened Index of Suspicion. Surgical Infections Case Reports 2016; 1(1) doi: 10.1089/crsi.2016.0039
|
| 40 |
Anastasia S. Ivanova, Olga A. Obukhova. Nutritional support as a part of complex therapy for clostridial infection. Clinical nutrition and metabolism 2023; 4(3) doi: 10.17816/clinutr623270
|
| 41 |
Kazuaki Matsumoto, Naoko Kanazawa, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa, Toyoyasu Koriyama, Michiyo Orita, Hideki Kawamura, Koichi Tokuda, Junichiro Nishi, Yasuo Takeda. Factors Affecting Treatment and Recurrence of <i>Clostridium difficile</i> Infections. Biological and Pharmaceutical Bulletin 2014; 37(11) doi: 10.1248/bpb.b14-00492
|
| 42 |
Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections. Infection and Chemotherapy 2010; 42(6) doi: 10.3947/ic.2010.42.6.323
|
| 43 |
Preetika Sinh, Terrence A. Barrett, Laura Yun. Clostridium difficileInfection and Inflammatory Bowel Disease: A Review. Gastroenterology Research and Practice 2011; 2011 doi: 10.1155/2011/136064
|
| 44 |
Courtney R. Murphy, Taliser R. Avery, Erik R. Dubberke, Susan S. Huang. Frequent Hospital Readmissions for Clostridium difficile Infection and the Impact on Estimates of Hospital-Associated C. difficile Burden. Infection Control & Hospital Epidemiology 2012; 33(1) doi: 10.1086/663209
|
| 45 |
David C. Kaslow, John W. Shiver. Clostridium difficile and Methicillin-Resistant Staphylococcus aureus: Emerging Concepts in Vaccine Development. Annual Review of Medicine 2011; 62(1) doi: 10.1146/annurev-med-051109-101544
|
| 46 |
Declan Bolton, Pilar Marcos. The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans. Foods 2023; 12(5) doi: 10.3390/foods12051094
|
| 47 |
Chang Soo Eun, Dong Soo Han. Advances in Endoscopy in Inflammatory Bowel Disease. 2018; doi: 10.1007/978-4-431-56018-0_13
|
| 48 |
Hsiao L Wei, Chun Wei Kao, Sung H Wei, Jason TC Tzen, Chien S Chiou. Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficile. BMC Microbiology 2011; 11(1) doi: 10.1186/1471-2180-11-217
|
| 49 |
Gösta Lotz, Jan Kloka, Linda Vo, Helga Häfner, Simone Scheithauer, Sebastian Lemmen. Die Intensivmedizin. Springer Reference Medizin 2023; doi: 10.1007/978-3-642-54675-4_83-2
|
| 50 |
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Hsin-Bai Yin, Shankumar Mooyottu, Kumar Venkitanarayanan. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile. Journal of Medical Microbiology 2019; 68(7) doi: 10.1099/jmm.0.001008
|
| 51 |
Sue Jung Kim, Heejung Kim, Younghee Seo, Dongeun Yong, Seok Hoon Jeong, Yunsop Chong, Kyungwon Lee. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea. Diagnostic Microbiology and Infectious Disease 2010; 67(2) doi: 10.1016/j.diagmicrobio.2010.01.007
|
| 52 |
Dukyong Yoon, Inwhee Park, Martijn J. Schuemie, Man Young Park, Ju Han Kim, Rae Woong Park, Indra Neil Sarkar. A Quantitative Method for Assessment of Prescribing Patterns Using Electronic Health Records. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0075214
|
| 53 |
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update. Surgery 2017; 162(2) doi: 10.1016/j.surg.2017.01.018
|
| 54 |
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Deepa Ashwarya Kuttappan, Neha Mishra, Breno de Oliveira Fragomeni, Kendra Maas, Shankumar Mooyottu, Kumar Venkitanarayanan. Protective Effect of Baicalin against Clostridioides difficile Infection in Mice. Antibiotics 2021; 10(8) doi: 10.3390/antibiotics10080926
|
| 55 |
Marinko Marušić. Is there a Connection between Inflammatory Bowel Disease Exacerbation, Clostridium difficile Infection and Thrombocytosis?. Archives of Clinical Gastroenterology 2016; doi: 10.17352/2455-2283.000017
|
| 56 |
H. Häfner, S. Scheithauer, S. Lemmen. Die Intensivmedizin. 2015; doi: 10.1007/978-3-642-54675-4_83-1
|
| 57 |
Guillermo Alvarez-Calatayud, Abelardo Margolles. Dual-Coated Lactic Acid Bacteria: An Emerging Innovative Technology in the Field of Probiotics. Future Microbiology 2016; 11(3) doi: 10.2217/fmb.15.150
|
| 58 |
M.R. Canales-Simón, M.J. Gil de Gómez-Barragán, A.M. Vázquez Medrano. Colitis pseudomembranosa en atención primaria. SEMERGEN - Medicina de Familia 2010; 36(10) doi: 10.1016/j.semerg.2010.04.007
|
| 59 |
Cristian Hernández-Rocha, Jonathan Barra-Carrasco, Manuel Álvarez-Lobos, Daniel Paredes-Sabja, Ana María Guzmán-Durán. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile–associated infections. Diagnostic Microbiology and Infectious Disease 2013; 75(4) doi: 10.1016/j.diagmicrobio.2012.12.010
|
| 60 |
Jennifer L. Cribb, Karly O'Brien, Christina E. DeRemer. Rifaximin in Combination with Metronidazole and Oral Vancomycin for the Treatment of an Initial Episode of Clostridium difficile–Associated Diarrhea: Case Report and Literature Review. Hospital Pharmacy 2012; 47(3) doi: 10.1310/hpj4703-206
|
| 61 |
Fred C. Tenover, Thomas Åkerlund, Dale N. Gerding, Richard V. Goering, Therése Boström, Anna-Maria Jonsson, Edith Wong, Alan T. Wortman, David H. Persing. Comparison of Strain Typing Results for Clostridium difficile Isolates from North America. Journal of Clinical Microbiology 2011; 49(5) doi: 10.1128/JCM.02446-10
|
| 62 |
Kiran K. Maddu, Pardeep Mittal, Waqas Shuaib, Anuj Tewari, Oluwayemisi Ibraheem, Faisal Khosa. Colorectal Emergencies and Related Complications: A Comprehensive Imaging Review—Imaging of Colitis and Complications. American Journal of Roentgenology 2014; 203(6) doi: 10.2214/AJR.13.12250
|
| 63 |
Jodie A. Barkin, Neilanjan Nandi, Nancimae Miller, Alexandra Grace, Jamie S. Barkin, Daniel A. Sussman. Superiority of the DNA Amplification Assay for the Diagnosis of C. difficile Infection: A Clinical Comparison of Fecal Tests. Digestive Diseases and Sciences 2012; 57(10) doi: 10.1007/s10620-012-2200-x
|
| 64 |
Rebecca J. Swett, G. Andrés Cisneros, Andrew L. Feig. Disruption of Intrinsic Motions as a Mechanism for Enzyme Inhibition. Biophysical Journal 2013; 105(2) doi: 10.1016/j.bpj.2013.05.031
|
| 65 |
TaeGyun Kim, MinJu Kim, JunHyung Lee, Joseph Moturi, SangHun Ha, Habeeb Tajudeen, JunYoung Mun, Abdolreza Hosseindoust, ByungJo Chae. Supplementation of nano-zinc in lower doses as an alternative to
pharmacological doses of ZnO in weanling pigs. Journal of Animal Science and Technology 2022; 64(1) doi: 10.5187/jast.2022.e2
|
| 66 |
Hiroshige Mikamo, Kazuhiro Tateda, Katsunori Yanagihara, Shinya Kusachi, Yoshio Takesue, Takashi Miki, Yuki Oizumi, Kazuaki Gamo, Atsuki Hashimoto, Junko Toyoshima, Kenichi Kato. Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan. Journal of Infection and Chemotherapy 2018; 24(9) doi: 10.1016/j.jiac.2018.05.010
|
| 67 |
Olga Sklenickova, Jaroslav Flesar, Ladislav Kokoska, Eva Vlkova, Katerina Halamova, Jan Malik. Selective Growth Inhibitory Effect of Biochanin A Against Intestinal Tract Colonizing Bacteria. Molecules 2010; 15(3) doi: 10.3390/molecules15031270
|
| 68 |
Ana E. Pérez-Cobas, Alejandro Artacho, Stephan J. Ott, Andrés Moya, MarÃa J. Gosalbes, Amparo Latorre. Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Frontiers in Microbiology 2014; 5 doi: 10.3389/fmicb.2014.00335
|
| 69 |
Cormac Magee, Victoria Blackwell, Simon Travis. Toxic dilatation of the colon. Medicine 2015; 43(3) doi: 10.1016/j.mpmed.2014.12.007
|
| 70 |
Beth A. Houser, Arthur L. Hattel, Bhushan M. Jayarao. Real-Time Multiplex Polymerase Chain Reaction Assay for Rapid Detection ofClostridium difficileToxin-Encoding Strains. Foodborne Pathogens and Disease 2010; 7(6) doi: 10.1089/fpd.2009.0483
|
| 71 |
Disaya Chavalitdhamrong, Gary C. Chen, Rome Jutabha. Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. 2010; doi: 10.1002/9781444328417.ch44
|
| 72 |
C Vaishnavi. ESTABLISHED AND POTENTIAL RISK FACTORS FOR CLOSTRIDUM DIFFICILE INFECTION. Indian Journal of Medical Microbiology 2009; 27(4) doi: 10.4103/0255-0857.55436
|
| 73 |
Syed Rahmanuddin, Daniel D. Von Hoff, Ammar Chaudhry, Danielle Guidaben, Marjaan Khan, William Boswell, Derek Cridebring, Jordyn Brase, Yuman Fong, Pejman Motarjem, Erkut Borazanci. Utilization of a novel 3D radiologic scoring method to define therapeutic response and surgical candidacy. Frontiers in Imaging 2023; 2 doi: 10.3389/fimag.2023.1117798
|
| 74 |
Dong Kil Na, Jin Bae Kim, Young Chul Shin, Su Lin Shin, Hyo Jung Kim, Il Hyun Baek, Sang Hoon Park, Myung Seok Lee. Left-sided Ulcerative Colitis Reactivated and Aggravated duringClostridium difficileInfection. The Korean Journal of Gastroenterology 2011; 57(6) doi: 10.4166/kjg.2011.57.6.374
|
| 75 |
Cynthia Susai, Julie Monteagudo, Francois I. Luks. Controversies in Pediatric Appendicitis. 2019; doi: 10.1007/978-3-030-15006-8_13
|
| 76 |
Hedley S. Roth, Christopher T. Parker, Roger J. Wale, Satish K. Warrier. Clostridium difficile-associated disease: how much do we really know? A single institution study. Healthcare infection 2014; 19(4) doi: 10.1071/HI14031
|
| 77 |
Manuel Ferrer Márquez, Álvaro Hernández Martínez, Ángel Reina Duarte, Rafael Rosado Cobián. Current Status of the Treatment of Fulminant Colitis. Cirugía Española (English Edition) 2015; 93(5) doi: 10.1016/j.cireng.2014.09.009
|
| 78 |
Theodore Rokkas, Javier P Gisbert, Antonio Gasbarrini, Georgina L Hold, Herbert Tilg, Peter Malfertheiner, Francis Megraud, Colm O'Morain. A network meta‐analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. United European Gastroenterology Journal 2019; 7(8) doi: 10.1177/2050640619854587
|
| 79 |
M. J. Aldape, D. D. Heeney, A. E. Bryant, D. L. Stevens. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile. Journal of Antimicrobial Chemotherapy 2015; 70(1) doi: 10.1093/jac/dku325
|
| 80 |
Chetana Vaishnavi. Clostridium difficile infection: clinical spectrum and approach to management. Indian Journal of Gastroenterology 2011; 30(6) doi: 10.1007/s12664-011-0148-y
|
| 81 |
Bogdan Arsic, Momcilo Pavlovic, Karolina Berenji. Risk Factors for Relapse and Mortality of Clostridium Difficile-Associated Diarrhea. Open Access Macedonian Journal of Medical Sciences 2014; 2(2) doi: 10.3889/oamjms.2014.040
|
| 82 |
Sheela S. Reddy, Lawrence J. Brandt. Clostridium difficile Infection and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2013; 47(8) doi: 10.1097/MCG.0b013e31828b288a
|
| 83 |
M. Beatriz Souza Dias, Juliana Yamashiro, Vera L. Borrasca, Valeska A. Stempliuk, Maria Rita E. Araújo, Silvia F. Costa, Anna S. Levin. Pseudo-outbreak of Clostridium difficile associated diarrhea (CDAD) in a tertiary-care hospital. Revista do Instituto de Medicina Tropical de São Paulo 2010; 52(3) doi: 10.1590/S0036-46652010000300004
|
| 84 |
Ekaterina G. Semenyuk, Michelle L. Laning, Jennifer Foley, Pehga F. Johnston, Katherine L. Knight, Dale N. Gerding, Adam Driks, Peter Setlow. Spore Formation and Toxin Production in Clostridium difficile Biofilms. PLoS ONE 2014; 9(1) doi: 10.1371/journal.pone.0087757
|
| 85 |
Jerzy Karczewski, Julie Zorman, Su Wang, Matthew Miezeiewski, Jinfu Xie, Keri Soring, Ioan Petrescu, Irene Rogers, David S. Thiriot, James C. Cook, Mihaela Chamberlin, Rachel F. Xoconostle, Debbie D. Nahas, Joseph G. Joyce, Jean-Luc Bodmer, Jon H. Heinrichs, Susan Secore. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine 2014; 32(24) doi: 10.1016/j.vaccine.2014.02.026
|
| 86 |
Soledad M. Smith. An Update on Clostridium difficile Infection and its Management. Nursing for Women's Health 2010; 14(5) doi: 10.1111/j.1751-486X.2010.01578.x
|
| 87 |
Priya D. Farooq, Nathalie H. Urrunaga, Derek M. Tang, Erik C. von Rosenvinge. Pseudomembranous colitis. Disease-a-Month 2015; 61(5) doi: 10.1016/j.disamonth.2015.01.006
|
| 88 |
Diane M. Citron, Kerin L. Tyrrell, Suzanne E. Dale, Laurent Chesnel, Ellie J. C. Goldstein. Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial. Antimicrobial Agents and Chemotherapy 2016; 60(4) doi: 10.1128/AAC.02531-15
|
| 89 |
Shipeng Yu, Ahmed Abdelkarim, Ali Nawras, Bryan Thomas Hinch, Chimaka Mbaso, Shahul Valavoor, Fadi Safi, Jeffrey Hammersley, Jianlin Tang, Ragheb Assaly. Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy. American Journal of Therapeutics 2016; 23(2) doi: 10.1097/MJT.0000000000000062
|
| 90 |
Stephen Harold, Herbert L. DuPont. Principles and Practice of Transplant Infectious Diseases. 2019; doi: 10.1007/978-1-4939-9034-4_16
|
| 91 |
Anca Trifan, Carol Stanciu, Oana Stoica, Irina Girleanu, Camelia Cojocariu. Impact of <italic>Clostridium difficile</italic> infection on inflammatory bowel disease outcome: A review. World Journal of Gastroenterology 2014; 20(33): 11736-11742 doi: 10.3748/wjg.v20.i33.11736
|
| 92 |
Eun Ae Cho, Kyung A Lee, Jae Song Kim, Soo Hyun Kim, Eun Sun Son. A Comparison of Vancomycin and Metronidazole for the Treatment ofClostridium difficile-associated Diarrhea (CDAD) in Medical Intensive Care Unit (MICU). Korean Journal of Clinical Pharmacy 2017; 27(2) doi: 10.24304/kjcp.2017.27.2.77
|
| 93 |
Shankumar Mooyottu, Genevieve Flock, Abhinav Upadhyay, Indu Upadhyaya, Kendra Maas, Kumar Venkitanarayanan. Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.00625
|
| 94 |
FS Ahmadi, Z Rezaee, FD Tanha, S Nekuie, S Abbasi. Pseudomemberanous Colitis following Cesarean Delivery with Adjunctive Intracolonic Vancomycin. Journal of Gynecological Research and Obstetrics 2016; 2(1) doi: 10.17352/jgro.000020
|
| 95 |
Ian R Poxton.
Fidaxomicin: A New Macrocyclic, RNA Polymerase-Inhibiting Antibiotic for the Treatment of
Clostridium Difficile
Infections
. Future Microbiology 2010; 5(4) doi: 10.2217/fmb.10.20
|
| 96 |
J.D. Stanley, J.G. Bartlett, B.W. Dart, J.H. Ashcraft. Clostridium difficile infection. Current Problems in Surgery 2013; 50(7) doi: 10.1067/j.cpsurg.2013.02.004
|
| 97 |
Shankumar Mooyottu, Genevieve Flock, Kumar Venkitanarayanan. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro
.
Journal of Medical Microbiology
2017; 66(8) doi: 10.1099/jmm.0.000515
|
| 98 |
Manuela Bianco, Giorgio Fedele, Adriano Quattrini, Patrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, Clara M. Ausiello. Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains.
Journal of Medical Microbiology
2011; 60(8) doi: 10.1099/jmm.0.029694-0
|
| 99 |
Mahfuzur R Sarker, Daniel Paredes-Sabja.
Molecular Basis of Early Stages of
Clostridium difficile
Infection: Germination and Colonization
. Future Microbiology 2012; 7(8) doi: 10.2217/fmb.12.64
|
| 100 |
Hung Chan, Shan Zhao, Lin Zhang, Jeffery Ho, Czarina C.H. Leung, Wai T. Wong, Yuanyuan Tian, Xiaodong Liu, Thomas N.Y. Kwong, Raphael C.Y. Chan, Sidney S.B. Yu, Maggie H.T. Wang, Gary Tse, Sunny H. Wong, Matthew T.V. Chan, William K.K. Wu. Clostridium difficile toxin B induces autophagic cell death in colonocytes. Journal of Cellular and Molecular Medicine 2018; 22(4) doi: 10.1111/jcmm.13555
|
| 101 |
Timothy McGuire, Paul Dobesh, Don Klepser, Mark Rupp, Keith Olsen. Clinically important interaction between statin drugs and Clostridium difficile toxin?. Medical Hypotheses 2009; 73(6) doi: 10.1016/j.mehy.2009.06.058
|
| 102 |
Jacob R. Sweeney, Carl V. Crawford, Rhonda K. Yantiss. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease. Histopathology 2022; 81(3) doi: 10.1111/his.14702
|
| 103 |
Jae Hyun Park, Kyung Ji Kang, Yu Na Kang, Ae Suk Kim, Jin-Bok Hwang. Pseudomembranous colitis in children: Experience of a university hospital in Korea. Korean Journal of Pediatrics 2010; 53(2) doi: 10.3345/kjp.2010.53.2.184
|
| 104 |
Helga Häfner, Sebastian Lemmen, Simone Scheithauer. Die Intensivmedizin. 2015; doi: 10.1007/978-3-642-54953-3_72
|
| 105 |
Chaitanya Pant, Abhishek Deshpande, Anne Larson, Judith O’Connor, David D.K. Rolston, Thomas J. Sferra. Diarrhea in solid-organ transplant recipients: a review of the evidence. Current Medical Research and Opinion 2013; 29(10) doi: 10.1185/03007995.2013.816278
|
| 106 |
Francisco Portela, Paula Lago. Fulminant colitis. Best Practice & Research Clinical Gastroenterology 2013; 27(5) doi: 10.1016/j.bpg.2013.08.011
|
| 107 |
Toshio Ohshima, Takako Osaki, Yukari Yamamoto, Satomi Asai, Hayato Miyachi, Shigeru Kamiya, Andrew B. Onderdonk. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay. Journal of Clinical Microbiology 2018; 56(12) doi: 10.1128/JCM.00555-18
|
| 108 |
Murali K. Yanda, William B. Guggino, Liudmila Cebotaru. A new role for heat shock factor 27 in the pathophysiology of Clostridium difficile toxin B. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1) doi: 10.1152/ajpgi.00166.2019
|
| 109 |
Hirotsugu Ozawa, Naoya Okada, Toru Nakamura, Minoru Takada, Yoshiyasu Ambo, Fumitaka Nakamura, Nobuichi Kashimura. A Case of Fulminant Clostridium difficile Colitis in Which Subtotal Colectomy Was Obviated by Performing Diverting Loop Ileostomy with Colonic Lavage. The Japanese Journal of Gastroenterological Surgery 2013; 46(12) doi: 10.5833/jjgs.2013.0085
|
| 110 |
Akhil A. Vinithakumari, Piyush Padhi, Belen Hernandez, Susanne Je-Han Lin, Aaron Dunkerson-Kurzhumov, Lucas Showman, Matthew Breitzman, Caroline Stokes, Yousuf Sulaiman, Chandra Tangudu, Deepa A. Kuttappan, Muhammed S. Muyyarikkandy, Auriel A. Willette, Gregory J. Phillips, Vellareddy Anantharam, Ann Perera, Brett A. Sponseller, Anumantha Kanthasamy, Shankumar Mooyottu, Karen C. Carroll. Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism. Microbiology Spectrum 2022; 10(2) doi: 10.1128/spectrum.00073-22
|
| 111 |
Chaitanya Pant, Abhishek Deshpande, Muhammad A. Altaf, Anil Minocha, Thomas J. Sferra. Clostridium difficileinfection in children: a comprehensive review. Current Medical Research and Opinion 2013; 29(8) doi: 10.1185/03007995.2013.803058
|
| 112 |
Sayf Al-Deen Hassouneh, Mark Loftus, Shibu Yooseph. Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.673632
|
| 113 |
Laura E. Raffals, Eugene B. Chang. Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut and Liver 2016; 10(4) doi: 10.5009/gnl15491
|
| 114 |
Ana Raquel Maia, Rodrigo Reyes-Ramírez, Marjorie Pizarro-Guajardo, Anella Saggese, Pablo Castro-Córdova, Rachele Isticato, Ezio Ricca, Daniel Paredes-Sabja, Loredana Baccigalupi. Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2ctd of Clostridioides difficile. International Journal of Molecular Sciences 2020; 21(4) doi: 10.3390/ijms21041277
|
| 115 |
B. Faris, A. Blackmore, N. Haboubi. Review of medical and surgical management of Clostridium difficile infection. Techniques in Coloproctology 2010; 14(2) doi: 10.1007/s10151-010-0574-3
|
| 116 |
Monica Viladomiu, Raquel Hontecillas, Lijuan Yuan, Pinyi Lu, Josep Bassaganya-Riera. Nutritional protective mechanisms against gut inflammation. The Journal of Nutritional Biochemistry 2013; 24(6) doi: 10.1016/j.jnutbio.2013.01.006
|
| 117 |
Des Field, Lisa Quigley, Paula M. O'Connor, Mary C. Rea, Karen Daly, Paul D. Cotter, Colin Hill, R. Paul Ross. Studies with bioengineered Nisin peptides highlight the broad‐spectrum potency of Nisin V. Microbial Biotechnology 2010; 3(4) doi: 10.1111/j.1751-7915.2010.00184.x
|
| 118 |
Lauren C. Ahyow, Paul C. Lambert, David R. Jenkins, Keith R. Neal, Martin Tobin. Bed Occupancy Rates and Hospital-Acquired Clostridium difficile Infection: A Cohort Study. Infection Control & Hospital Epidemiology 2013; 34(10) doi: 10.1086/673156
|
| 119 |
Alyssa Liubakka, Byron P. Vaughn. Clostridium difficile Infection and Fecal Microbiota Transplant. AACN Advanced Critical Care 2016; 27(3) doi: 10.4037/aacnacc2016703
|
| 120 |
Suresh Keshavamurthy, Colleen G. Koch, Thomas G. Fraser, Steven M. Gordon, Penny L. Houghtaling, Edward G. Soltesz, Eugene H. Blackstone, Gösta B. Pettersson. Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization. The Journal of Thoracic and Cardiovascular Surgery 2014; 148(6) doi: 10.1016/j.jtcvs.2014.08.017
|
| 121 |
Matthias G Hautmann, Matthias Hipp, Oliver Kölbl. Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?. Radiation Oncology 2011; 6(1) doi: 10.1186/1748-717X-6-89
|
| 122 |
Michelle M. Nerandzic, Curtis J. Donskey, Peter Setlow. Activate to Eradicate: Inhibition of Clostridium difficile Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin. PLoS ONE 2013; 8(1) doi: 10.1371/journal.pone.0054740
|
| 123 |
Yong-Sang Kim, Hong-Jun Jeon, Su-A Nam, Byung Moon Cho, Se-Hyuck Park, Se Moon Oh. Analysis of Clinical Characteristics and Risk Factors to Neurosurgical Patients withClostridium Difficile-Associated Diarrhea. Journal of Korean Neurotraumatology Society 2011; 7(2) doi: 10.13004/jknts.2011.7.2.92
|
| 124 |
Gösta Lotz, Jan Kloka, Linda Vo, Helga Häfner, Simone Scheithauer, Sebastian Lemmen. Die Intensivmedizin. Springer Reference Medizin 2024; doi: 10.1007/978-3-662-68699-7_83
|
| 125 |
A. Castillo, J. López, E. Panadero, J. Cerdá, B. Padilla, A. Bustinza. Conservative surgical treatment for toxic megacolon due to Clostridium difficile infection in a transplanted pediatric patient. Transplant Infectious Disease 2012; 14(4) doi: 10.1111/j.1399-3062.2012.00756.x
|
| 126 |
Ae Sol Lee, Hye Ryoung Heo, Young Hoon Song, Chang Sup Kim, Jeong Hyun Seo, Hyung Joon Cha. Exploiting glycan arrays and biosensors to diagnose and understand diseases. Biotechnology Advances 2025; 83 doi: 10.1016/j.biotechadv.2025.108635
|
| 127 |
Kelly C. Sandberg, Matthew M. Davis, Achamyeleh Gebremariam, Jeremy Adler. Disproportionate Rise in Clostridium difficile–Associated Hospitalizations Among US Youth With Inflammatory Bowel Disease, 1997–2011. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(4) doi: 10.1097/MPG.0000000000000636
|
| 128 |
A.R. Hosseindoust, S.H. Lee, J.S. Kim, Y.H. Choi, H.S. Noh, J.H. Lee, P.K. Jha, I.K. Kwon, B.J. Chae. Dietary bacteriophages as an alternative for zinc oxide or organic acids to control diarrhoea and improve the performance of weanling piglets. Veterinární medicína 2017; 62(2) doi: 10.17221/7/2016-VETMED
|
| 129 |
Ying Nie, Qinlu Lin, Feijun Luo. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. International Journal of Molecular Sciences 2017; 18(7) doi: 10.3390/ijms18071372
|
| 130 |
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficile. Journal of Parenteral and Enteral Nutrition 2012; 36(6) doi: 10.1177/0148607112446703
|
| 131 |
M.J.G.T. Vehreschild, J.J. Vehreschild, K. Hübel, M. Hentrich, M. Schmidt-Hieber, M. Christopeit, G. Maschmeyer, E. Schalk, O.A. Cornely, S. Neumann. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Oncology 2013; 24(5) doi: 10.1093/annonc/mdt001
|
| 132 |
Ana Pérez-Cobas, Andrés Moya, María Gosalbes, Amparo Latorre. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics 2015; 4(3) doi: 10.3390/antibiotics4030337
|
| 133 |
Shankumar Mooyottu, Anup Kollanoor-Johny, Genevieve Flock, Laurent Bouillaut, Abhinav Upadhyay, Abraham Sonenshein, Kumar Venkitanarayanan. Carvacrol and trans-Cinnamaldehyde Reduce Clostridium difficile Toxin Production and Cytotoxicity in Vitro. International Journal of Molecular Sciences 2014; 15(3) doi: 10.3390/ijms15034415
|
| 134 |
Ming-fei WANG, Zhao DING, Jian ZHAO, Cong-qing JIANG, Zhi-su LIU, Qun QIAN. Current role of surgery for the treatment of fulminant Clostridium difficile colitis. Chinese Medical Journal 2013; 126(5) doi: 10.3760/cma.j.issn.0366-6999.20111537
|
| 135 |
Christian Larbi Ayisi, Samuel Ayeh Osei, Grace Afumwaa Boamah, Gertrude Dzifa Mensah. Microbial communities and functional diversity in seafood. JSFA reports 2026; doi: 10.1002/jsf2.70067
|
| 136 |
Adedamola S. Arojojoye, Samuel G. Awuah. Functional utility of gold complexes with phosphorus donor ligands in biological systems. Coordination Chemistry Reviews 2025; 522 doi: 10.1016/j.ccr.2024.216208
|
| 137 |
Manoj Kumar, Tarun Mathur, Tarani K. Barman, G. Ramkumar, Ashish Bhati, Gunjan Shukla, Vandana Kalia, Manisha Pandya, V. Samuel Raj, Dilip J. Upadhyay, Chetana Vaishnavi, Anjan Chakrabarti, Biswajit Das, Pradip K. Bhatnagar.
In Vitro
and
In Vivo
Activities of the Novel Ketolide RBx 14255 against Clostridium difficile
. Antimicrobial Agents and Chemotherapy 2012; 56(11) doi: 10.1128/AAC.00015-12
|
| 138 |
Ellen Cesewski, Blake N. Johnson. Electrochemical biosensors for pathogen detection. Biosensors and Bioelectronics 2020; 159 doi: 10.1016/j.bios.2020.112214
|
| 139 |
Michelle D Cairns, Richard A Stabler, Nandini Shetty, Brendan W Wren.
The Continually Evolving
Clostridium difficile
Species
. Future Microbiology 2012; 7(8) doi: 10.2217/fmb.12.73
|
| 140 |
Martha R Herbert. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Current Opinion in Neurology 2010; 23(2) doi: 10.1097/WCO.0b013e328336a01f
|
| 141 |
Ilana T. Balassiano, Joaquim dos Santos-Filho, Juliana M. Vital-Brazil, Simone A. Nouér, Claudia R. C. Souza, Jon S. Brazier, Eliane de O. Ferreira, Regina M. C. P. Domingues. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil. Antonie van Leeuwenhoek 2011; 99(2) doi: 10.1007/s10482-010-9483-8
|
| 142 |
Chao Chen, Naveen K. Dolla, Gabriele Casadei, John B. Bremner, Kim Lewis, Michael J. Kelso. Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells. Bioorganic & Medicinal Chemistry Letters 2014; 24(2) doi: 10.1016/j.bmcl.2013.12.015
|
| 143 |
Sayeda Nasrin Alam, Halim Yammine, Omeed Moaven, Rizwan Ahmed, Angela K. Moss, Brishti Biswas, Nur Muhammad, Rakesh Biswas, Atri Raychowdhury, Kanakaraju Kaliannan, Sathi Ghosh, Madhury Ray, Sulaiman R. Hamarneh, Soumik Barua, Nondita S. Malo, Atul K. Bhan, Madhu S. Malo, Richard A. Hodin. Intestinal Alkaline Phosphatase Prevents Antibiotic-Induced Susceptibility to Enteric Pathogens. Annals of Surgery 2014; 259(4) doi: 10.1097/SLA.0b013e31828fae14
|
| 144 |
Darius Gawlik, Peter Slickers, Ines Engelmann, Elke Müller, Christian Lück, Anette Friedrichs, Ralf Ehricht, Stefan Monecke. DNA-Microarray-based Genotyping of Clostridium difficile
. BMC Microbiology 2015; 15(1) doi: 10.1186/s12866-015-0489-2
|
| 145 |
Şükrü ÖKSÜZ, Ayşe DANIŞ, Elif ÖZTÜRK, Emel ÇALIŞKAN, Nida KILIÇ AKAR, Mehmet Ali SUNGUR. Hastanede uzun süreli yatan hastalarda Clostridium difficile kolonizasyonunun araştırılması. Anadolu Kliniği Tıp Bilimleri Dergisi 2017; doi: 10.21673/anadoluklin.298926
|
| 146 |
Faith Rohlke, Neil Stollman. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therapeutic Advances in Gastroenterology 2012; 5(6) doi: 10.1177/1756283X12453637
|
| 147 |
Yinghong Wang, Ashish Atreja, Xianrui Wu, Bret A. Lashner, Aaron Brzezinski, Bo Shen. Similar Outcomes of IBD Inpatients with Clostridium difficile Infection Detected by ELISA or PCR Assay. Digestive Diseases and Sciences 2013; 58(8) doi: 10.1007/s10620-013-2641-x
|
| 148 |
V. K. Viswanathan, Michael Mallozzi, Gayatri Vedantam. Clostridium difficileinfection. Gut Microbes 2010; 1(4) doi: 10.4161/gmic.1.4.12706
|
| 149 |
Nuntra Suwantarat, David A. Bobak. Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection. Current Infectious Disease Reports 2011; 13(1) doi: 10.1007/s11908-010-0155-7
|
| 150 |
Raquel Salazar-Kagunye, Anish Shah, Gina Loshkajian, Walid Baddoura, Vincent A DeBari.
Association of Decreased Serum Protein Fractions with
Clostridium Difficile
Infection in the Acute Care Setting: A Case–Control Study
. Biomarkers in Medicine 2012; 6(5) doi: 10.2217/bmm.12.52
|
| 151 |
Jacek Czepiel, Mirosław Dróżdż, Hanna Pituch, Ed J. Kuijper, William Perucki, Aleksandra Mielimonka, Sarah Goldman, Dorota Wultańska, Aleksander Garlicki, Grażyna Biesiada. Clostridium difficile infection: review. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(7) doi: 10.1007/s10096-019-03539-6
|
| 152 |
Julio Cesar de Oliveira, Martino Martinelli, Andre D'Avila, Stephan Danik. Response to the Letter Regarding Article “Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-Defibrillators”. Circulation: Arrhythmia and Electrophysiology 2009; 2(3) doi: 10.1161/CIRCEP.109.877076
|
| 153 |
B. Guo, C. Harstall, T. Louie, S. Veldhuyzen van Zanten, L. A. Dieleman. Systematic review: faecal transplantation for the treatment of Clostridium difficile‐associated disease. Alimentary Pharmacology & Therapeutics 2012; 35(8) doi: 10.1111/j.1365-2036.2012.05033.x
|
| 154 |
Michael J. Aldape, Aaron E. Packham, Dustin D. Heeney, Savannah N. Rice, Amy E. Bryant, Dennis L. Stevens. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficile
in vitro
.
Journal of Medical Microbiology
2017; 66(10) doi: 10.1099/jmm.0.000580
|
| 155 |
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Kumar Venkitanarayanan.
In vitro antivirulence activity of baicalin against Clostridioides difficile
.
Journal of Medical Microbiology
2020; 69(4) doi: 10.1099/jmm.0.001179
|
| 156 |
Ilana Teruszkin Balassiano, Joaquim dos Santos-Filho, Márcia Pinto Barros de Oliveira, Maria Catarina Ramos, Andre M. Japiassu, Alessandro Mendonça dos Reis, Jon S. Brazier, Eliane de Oliveira Ferreira, Regina Maria Cavalcanti Pilotto Domingues. An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagnostic Microbiology and Infectious Disease 2010; 68(4) doi: 10.1016/j.diagmicrobio.2010.07.017
|
| 157 |
Michel R. Popoff, Philippe Bouvet. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 2013; 75 doi: 10.1016/j.toxicon.2013.05.003
|
| 158 |
Abdulwahab Ali Abuderman, Ayesha Mateen, Rabbani Syed, Mustafa sawsan aloahd. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes. Microbial Pathogenesis 2018; 120 doi: 10.1016/j.micpath.2018.04.013
|
| 159 |
P.-J. Maziade, J.A. Andriessen, P. Pereira, B. Currie, E.J.C. Goldstein. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital. Current Medical Research and Opinion 2013; 29(10) doi: 10.1185/03007995.2013.833501
|
| 160 |
I. T. Balassiano, E. A. Yates, R. M. C. P. Domingues, E. O. Ferreira. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. Journal of Medical Microbiology 2012; 61(2) doi: 10.1099/jmm.0.037077-0
|
| 161 |
Resha Menon, Pushpa Mahadevan, Merin Jaison. Histopathological spectrum of infectious diseases in endoscopic mucosal biopsies of the gastrointestinal tract: A one-year study at a tertiary care hospital in Kerala. Indian Journal of Pathology and Oncology 2024; 11(1) doi: 10.18231/j.ijpo.2024.006
|
| 162 |
Fabio Miyajima, Paul Roberts, Andrew Swale, Valerie Price, Maureen Jones, Michael Horan, Nicholas Beeching, Jonathan Brazier, Christopher Parry, Neil Pendleton, Munir Pirmohamed, Markus M. Heimesaat. Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom. PLoS ONE 2011; 6(8) doi: 10.1371/journal.pone.0022804
|
| 163 |
Michael John Aldape, Aaron Eugene Packham, Drew William Nute, Amy Evelyn Bryant, Dennis Leroy Stevens. Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile
.
Journal of Medical Microbiology
2013; 62(5) doi: 10.1099/jmm.0.056218-0
|
| 164 |
Hye Jung Cho, Eell Ryoo, Yong Han Sun, Kang Ho Cho, Dong Woo Son, Hann Tchah. Epidemiology and Clinical Characteristics ofClostridium difficile-associated Disease in Children: Comparison between Community- and Hospital-acquired Infections. Korean Journal of Pediatric Gastroenterology and Nutrition 2010; 13(2) doi: 10.5223/kjpgn.2010.13.2.146
|
| 165 |
E. Hofer, H. Haechler, R. Frei, R. Stephan. Low Occurrence of Clostridium difficile in Fecal Samples of Healthy Calves and Pigs at Slaughter and in Minced Meat in Switzerland. Journal of Food Protection 2010; 73(5) doi: 10.4315/0362-028X-73.5.973
|
| 166 |
Wasef Na’amnih, Amos Adler, Tamar Miller-Roll, Dani Cohen, Yehuda Carmeli. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(7) doi: 10.1007/s10096-018-3247-1
|
| 167 |
Jonathan Barra-Carrasco, Daniel Paredes-Sabja.
Clostridium difficile
Spores: A Major Threat to the Hospital Environment
. Future Microbiology 2014; 9(4) doi: 10.2217/fmb.14.2
|
| 168 |
J. M. Wenisch, D. Schmid, H.-W. Kuo, E. Simons, F. Allerberger, V. Michl, P. Tesik, G. Tucek, C. Wenisch. Hospital-acquired Clostridium difficile infection: determinants for severe disease. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(8) doi: 10.1007/s10096-011-1522-5
|
| 169 |
Moacyr Silva Júnior. Recent changes in Clostridium difficile infection. Einstein (São Paulo) 2012; 10(1) doi: 10.1590/S1679-45082012000100023
|
| 170 |
Akira Andoh, Shigeki Bamba. Current Status of <I>Clostridium Difficile</I> Infection. Nippon Daicho Komonbyo Gakkai Zasshi 2018; 71(10) doi: 10.3862/jcoloproctology.71.456
|
| 171 |
Giuseppe Caramia, Stefania Silvi. Probiotic Bacteria and Enteric Infections. 2011; doi: 10.1007/978-94-007-0386-5_1
|
| 172 |
Helga Häfner, Susanne Koch, Sebastian Lemmen. Die Intensivmedizin. 2011; doi: 10.1007/978-3-642-16929-8_64
|
| 173 |
J. Viala, M. Lorrot, L. Pull, P. Mariani-Kurkdjian, L. Paris, M. Bellaïche, A. Smail, J.-Y. Siriez. Gastroentérites aiguës de l’enfant. EMC - Maladies infectieuses 2013; 30(1) doi: 10.1016/S1166-8598(12)57862-2
|
| 174 |
M. Parthasarathy, D. Bowers, T. Groot‐Wassink. Do preoperative oral antibiotics increase Clostridium difficile infection rates? An analysis of 13 959 colectomy patients. Colorectal Disease 2018; 20(6) doi: 10.1111/codi.13926
|
| 175 |
Kanika Sehgal, Paul Feuerstadt. The Changing Epidemiology of Clostridioides difficile Infection. Gastroenterology Clinics of North America 2026; doi: 10.1016/j.gtc.2026.05.001
|
| 176 |
Sean Fitzwater, Aruna Chandran, Margaret Kosek, Mathuram Santosham. Water and Sanitation‐Related Diseases and the Environment. 2011; doi: 10.1002/9781118148594.ch5
|
| 177 |
Tammy A. Novotne, Hatem O. Kaseb. The changing face of Clostridium difficile in critical care. Nursing Critical Care 2013; 8(3) doi: 10.1097/01.CCN.0000429383.25720.13
|
| 178 |
Jason Fawley, David M. Gourlay. Intestinal alkaline phosphatase: a summary of its role in clinical disease. Journal of Surgical Research 2016; 202(1) doi: 10.1016/j.jss.2015.12.008
|
| 179 |
Massimo Sartelli, Stefano Di Bella, Lynne V. McFarland, Sahil Khanna, Luis Furuya-Kanamori, Nadir Abuzeid, Fikri M. Abu-Zidan, Luca Ansaloni, Goran Augustin, Miklosh Bala, Offir Ben-Ishay, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria E. Cocuz, Raul Coimbra, Francesco Cortese, Yunfeng Cui, Jacek Czepiel, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina M. Dumitru, Christian Eckmann, Edward H. Eiland, Joseph D. Forrester, Gustavo P. Fraga, Jean L. Frossard, Donald E. Fry, Rita Galeiras, Wagih Ghnnam, Carlos A. Gomes, Ewen A. Griffiths, Xavier Guirao, Mohamed H. Ahmed, Torsten Herzog, Jae Il Kim, Tariq Iqbal, Arda Isik, Kamal M. F. Itani, Francesco M. Labricciosa, Yeong Y. Lee, Paul Juang, Aleksandar Karamarkovic, Peter K. Kim, Yoram Kluger, Ari Leppaniemi, Varut Lohsiriwat, Gustavo M. Machain, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick A. Moore, Carlos A. Ordoñez, Leonardo Pagani, Nicola Petrosillo, Francisco Portela, Kemal Rasa, Miran Rems, Boris E. Sakakushev, Helmut Segovia-Lohse, Gabriele Sganga, Vishal G. Shelat, Patrizia Spigaglia, Pierre Tattevin, Cristian Tranà, Libor Urbánek, Jan Ulrych, Pierluigi Viale, Gian L. Baiocchi, Fausto Catena. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World Journal of Emergency Surgery 2019; 14(1) doi: 10.1186/s13017-019-0228-3
|
| 180 |
Michel R Popoff, Philippe Bouvet. Clostridial Toxins. Future Microbiology 2009; 4(8) doi: 10.2217/fmb.09.72
|
| 181 |
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, Jochen Maul, Yami Shapira, Daniela Bojic, Irit Chermesh, Ahmad Al-Rifai, Alain Schoepfer, Matteo Bosani, Matthieu Allez, Peter Laszlo Lakatos, Fabrizio Bossa, Alexander Eser, Tommaso Stefanelli, Franck Carbonnel, Konstantinos Katsanos, Davide Checchin, Inés Sáenz de Miera, Walter Reinisch, Yehuda Chowers, Gordon William Moran. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. Journal of Crohn's and Colitis 2010; 4(2) doi: 10.1016/j.crohns.2009.11.001
|
| 182 |
Lawrence J. Brandt, Sheela S. Reddy. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Journal of Clinical Gastroenterology 2011; 45 doi: 10.1097/MCG.0b013e318222e603
|
| 183 |
Helena Lomba Viana. Clostridium difficile: infeção e ribotipos. GE Jornal Português de Gastrenterologia 2013; 20(6) doi: 10.1016/j.jpg.2013.09.001
|
| 184 |
Sean Fitzwater, Anita Shet, Mathuram Santosham, Margaret Kosek. Water and Sanitation‐Related Diseases and the Changing Environment. 2019; doi: 10.1002/9781119415961.ch7
|
| 185 |
Michael John Aldape, Savannah Nicole Rice, Kevin Patrick Field, Amy Evelyn Bryant, Dennis Leroy Stevens. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro. Journal of Medical Microbiology 2018; 67(12) doi: 10.1099/jmm.0.000852
|
| 186 |
Khalid A Osman, Mohamed H Ahmed, Mahir A Hamad, Dilip Mathur. Emergency colectomy for fulminantClostridium difficilecolitis: Striking the right balance. Scandinavian Journal of Gastroenterology 2011; 46(10) doi: 10.3109/00365521.2011.605469
|
| 187 |
Gizem ADAN, Nafiye URGANCI, Ayşe Ayşim ÖZAĞARI. Clostiridium difficile enfeksiyonuna eşlik eden protein kaybettiren enteropati olgusu. Akademik Gastroenteroloji Dergisi 2022; 21(1) doi: 10.17941/agd.1100119
|
| 188 |
Alicia R. Desilets, Nicole J. Asal, Kaelen C. Dunican. Considerations for the Use of Proton-Pump Inhibitors in Older Adults. The Consultant Pharmacist 2012; 27(2) doi: 10.4140/TCP.n.2012.114
|
| 189 |
Rajiv Gandhi Gopalsamy, Poovathumkal James Antony, Kumaraswamy Athesh, Varghese Edwin Hillary, Monalisa Martins Montalvão, Govindasamy Hariharan, Lucas Alves da Mota Santana, Lysandro Pinto Borges, Ricardo Queiroz Gurgel. Dietary essential oil components: A systematic review of preclinical studies on the management of gastrointestinal diseases. Phytomedicine 2025; 140 doi: 10.1016/j.phymed.2025.156630
|
| 190 |
Pamela Sears, Yoshi Ichikawa, Nancy Ruiz, Sherwood Gorbach. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic. Annals of the New York Academy of Sciences 2013; 1291(1) doi: 10.1111/nyas.12135
|
| 191 |
Clara Lina Salazar, Catalina Reyes, Astrid Vanessa Cienfuegos-Gallet, Emma Best, Santiago Atehortua, Patricia Sierra, Margarita M. Correa, Warren N. Fawley, Daniel Paredes-Sabja, Mark Wilcox, Angel Gonzalez, Baochuan Lin. Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia. PLOS ONE 2018; 13(4) doi: 10.1371/journal.pone.0195694
|
| 192 |
Elizabeth J. Kvach, David Ferguson, Paul F. Riska, Marie L. Landry.
Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic
Clostridium difficile
Infection
. Journal of Clinical Microbiology 2010; 48(1) doi: 10.1128/JCM.01630-09
|
| 193 |
Stefano Di Bella, Gianfranco Sanson, Jacopo Monticelli, Verena Zerbato, Luigi Principe, Mauro Giuffrè, Giuseppe Pipitone, Roberto Luzzati, Christopher Staley, Mayuresh Abhyankar.
Clostridioides difficile
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
. Clinical Microbiology Reviews 2024; 37(2) doi: 10.1128/cmr.00135-23
|
| 194 |
Alica Hokynková, Hana Paulová, Petr Šín, Marie Nováková, Petr Babula, Andrea Pokorná. Nutritional and biochemical insights into multiple pressure ulcer management: a case report. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1564879
|
| 195 |
Lynne V McFarland. Emerging therapies forClostridium difficileinfections. Expert Opinion on Emerging Drugs 2011; 16(3) doi: 10.1517/14728214.2011.571204
|
| 196 |
Mehdi Goudarzi, Hossein Goudarzi, Masoud Alebouyeh, Masoumeh Azimi Rad, Farahnaz Sadat Shayegan Mehr, Mohammad Reza Zali, Mohammad Mehdi Aslani. Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran. Iranian Red Crescent Medical Journal 2013; 15(8) doi: 10.5812/ircmj.5189
|
| 197 |
Danielle Angst Secco, Ilana Teruszkin Balassiano, Renata Ferreira Boente, Karla Rodrigues Miranda, Jon Brazier, Val Hall, Joaquim dos Santos-Filho, Leandro Araujo Lobo, Simone Aranha Nouér, Regina Maria Cavalcanti Pilotto Domingues. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain. Anaerobe 2014; 28 doi: 10.1016/j.anaerobe.2014.05.013
|
| 198 |
Abhinav Upadhyay, Shankumar Mooyottu, Hsinbai Yin, Meera Nair, Varunkumar Bhattaram, Kumar Venkitanarayanan. Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts. Medicines 2015; 2(3) doi: 10.3390/medicines2030186
|
| 199 |
X. Wu, P. T. Cherian, R. E. Lee, J. G. Hurdle. The membrane as a target for controlling hypervirulent Clostridium difficile infections. Journal of Antimicrobial Chemotherapy 2013; 68(4) doi: 10.1093/jac/dks493
|
| 200 |
A. Sarkar, C.S. Pitchumoni. The Microbiota in Gastrointestinal Pathophysiology. 2017; doi: 10.1016/B978-0-12-804024-9.00004-5
|
| 201 |
Rebecca Swett, G. Andrés Cisneros, Andrew L. Feig, Jörg Langowski. Conformational Analysis of Clostridium difficile Toxin B and Its Implications for Substrate Recognition. PLoS ONE 2012; 7(7) doi: 10.1371/journal.pone.0041518
|
| 202 |
Matthew J. Delano, Joseph Cuschieri. Surgical Management ofClostridium difficileInfection: The Role of Colectomy. Surgical Infections 2016; 17(3) doi: 10.1089/sur.2016.004
|
| 203 |
|
| 204 |
Junichi Sasaki. Judicious use of antimicrobial agents in a field of emergency and critical care. Nihon Kyukyu Igakukai Zasshi 2010; 21(11) doi: 10.3893/jjaam.21.871
|
| 205 |
Maria Carmen Collado, Erika Isolauri, Kirsi Laitinen, Seppo Salminen. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. The American Journal of Clinical Nutrition 2010; 92(5) doi: 10.3945/ajcn.2010.29877
|
| 206 |
Theresa D. Ho, Craig D. Ellermeier, A. Camilli. PrsW Is Required for Colonization, Resistance to Antimicrobial Peptides, and Expression of Extracytoplasmic Function σ Factors in Clostridium difficile. Infection and Immunity 2011; 79(8) doi: 10.1128/IAI.00019-11
|
| 207 |
Rosanna Leuzzi, Janice Spencer, Anthony Buckley, Cecilia Brettoni, Manuele Martinelli, Lorenza Tulli, Sara Marchi, Enrico Luzzi, June Irvine, Denise Candlish, Daniele Veggi, Werner Pansegrau, Luigi Fiaschi, Silvana Savino, Erwin Swennen, Osman Cakici, Ernesto Oviedo-Orta, Monica Giraldi, Barbara Baudner, Nunzia D'Urzo, Domenico Maione, Marco Soriani, Rino Rappuoli, Mariagrazia Pizza, Gillian R. Douce, Maria Scarselli, B. A. McCormick. Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments. Infection and Immunity 2013; 81(8) doi: 10.1128/IAI.01341-12
|
| 208 |
Joao B. Rezende-Neto, Ori D. Rotstein. Abdominal Catastrophes in the Intensive Care Unit Setting. Critical Care Clinics 2013; 29(4) doi: 10.1016/j.ccc.2013.06.005
|
| 209 |
Shankumar Mooyottu, Genevieve Flock, Anup Kollanoor-Johny, Indu Upadhyaya, Bhushan Jayarao, Kumar Venkitanarayanan. Characterization of a multidrug resistant C. difficile meat isolate. International Journal of Food Microbiology 2015; 192 doi: 10.1016/j.ijfoodmicro.2014.10.002
|
| 210 |
Sheridan J C Baker, Julia Maciejewski, Mary-Theresa Usuanlele, Jodi Gilchrist, Dhundi Raj Sharma, David Bulir, Marek Smieja, Mark Loeb, Michael G Surette, Andrew G McArthur, Dominik Mertz. Investigating in-hospital transmission of Clostridioides difficile from asymptomatic patients. Journal of the Association of Medical Microbiology and Infectious Disease Canada 2025; 10(3) doi: 10.3138/jammi-2024-0041
|
| 211 |
Victoria Blackwell, Simon Travis. Toxic dilatation of the colon. Medicine 2011; 39(2) doi: 10.1016/j.mpmed.2010.11.002
|
| 212 |
Kai B. Dallas, Audree Condren, Celia M. Divino. Life after colectomy for fulminant Clostridium difficile colitis: a 7-year follow up study. The American Journal of Surgery 2014; 207(4) doi: 10.1016/j.amjsurg.2013.04.008
|
| 213 |
Meenakshi Singh, Chetana Vaishnavi, Safrun Mahmood, Rakesh Kochhar. Toxinotyping and Sequencing of Clostridium difficile Isolates from Patients in a Tertiary Care Hospital of Northern India. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00033
|